The National Institutes of Health (NIH) is the largest medical research institute and scientific research fund management institution. It funds research projects designed to deal with major diseases that threaten human health around the world. It invests nearly $37.3 billion annually in medical research. More than 80% of the funding is awarded through nearly 50,000 competitive grants to more than 300,000 researchers at more than 2500 universities, medical schools, and other research institutions around the world. By doing this, NIH encourages these researchers to engage in scientific research for the benefit of the life and health of mankind. The funding effort, NIH-funded institutions, and project list somewhat reflects the trend of life sciences and healthcare researches.
The Genetic Engineering & Biotechnology News (GEN) recently released the list of top 50 scientific research institutions Funded by NIH in 2018, which was based on how much NIH funding the institutions have received during the current 2018 fiscal year, through May 29. (Note: NIH fiscal year 2018 ends on September 30).
This year’s Top 50 List almost mirrors GEN’s Top 10 U.S. Biopharma Clusters List published last year. Among the 26 states with at least one institution among the top 50 listed here, California and Massachusetts lead the nation, with seven institutions in each state receiving NIH grant funding. Next-highest is New York with five NIH-funded institutions. These three states combined account for more than one-third (19) of the top 50 NIH-funded institutions in the current 2018 federal fiscal year. Those states were followed by eight states with two institutions each (Illinois, Maryland, Minnesota, North Carolina, Ohio, Pennsylvania, Texas, and Washington state). Another 15 states have a single NIH-funded institution among the top 50 listed here.
The detailed list is as follows.
The Genetic Engineering & Biotechnology News (GEN) recently released the list of top 50 scientific research institutions Funded by NIH in 2018, which was based on how much NIH funding the institutions have received during the current 2018 fiscal year, through May 29. (Note: NIH fiscal year 2018 ends on September 30).
This year’s Top 50 List almost mirrors GEN’s Top 10 U.S. Biopharma Clusters List published last year. Among the 26 states with at least one institution among the top 50 listed here, California and Massachusetts lead the nation, with seven institutions in each state receiving NIH grant funding. Next-highest is New York with five NIH-funded institutions. These three states combined account for more than one-third (19) of the top 50 NIH-funded institutions in the current 2018 federal fiscal year. Those states were followed by eight states with two institutions each (Illinois, Maryland, Minnesota, North Carolina, Ohio, Pennsylvania, Texas, and Washington state). Another 15 states have a single NIH-funded institution among the top 50 listed here.
The detailed list is as follows.